Report #2897980

Overview

Sex

Unknown

Age

Age unknown

State

WA

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (2)

Symptom narrative

Suspected vaccination failure; patients had a shingles case after completing the Shingrix scheme; This serious case was reported by a pharmacist via call center representative and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingrix) solution for injection for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: patients had a shingles case after completing the Shingrix scheme). The outcome of the vaccination failure was not reported and the outcome of the shingles was unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix. The company considered the vaccination failure to be unrelated to Shingrix. Additional Information: GSK Receipt Date: 20-MAY-2026 This case was considered as suspected vaccination failure as details regarding completion of time to onset and laboratory test confirming shingles were unknown at the time of reporting The case has been linked with case US2026068438 and US2026068452 reported by same reporter. The batch number was not provided upon follow up with the reporter; Sender's Comments: A case of Vaccination failure, unknown time after receiving 1st dose and 2nd dose of Shingrix in a patient. Case lacks further information on time to onset, medical history, concurrent conditions and laboratory confirmation. Based on the available information a possible causality that the event was caused by the GSK product cannot be ascertained. Consent for further follow-up has not been received.